United Therapeutics Overview
United Therapeutics Target Price
Analysts' 12-month price predictions for UTHR.
Share Price
$290.75
Average Target Price
$314.00
8% upside
8% upside1 analysts in the last 4 months
High: $314 | Low: $314
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-25 | Wells FargoTiago Fauth | $314 | 8% upside |  |
| 2024-10-31 | Argus ResearchJasper Hellweg | $400 | 37.6% upside | |
| 2024-10-31 | H.C. WainwrightAndrew Fein | $425 | 46.2% upside | |
| 2024-09-23 | JefferiesEun Yang | $432 | 48.6% upside | |
| 2024-08-28 | OppenheimerHartaj Singh | $575 | 97.8% upside | |
| 2024-07-08 | UBSAshwani Verma | $370 | 27.3% upside | |
| 2024-06-12 | Wells FargoTiago Fauth | $350 | 20.4% upside | |
| 2024-05-02 | OppenheimerHartaj Singh | $400 | 37.6% upside | |
| 2024-02-12 | Goldman SachsChris Shibutani | $215 |  26.1% downside | |
| 2023-01-11 | Argus Research | $300 | 3.2% upside | |
| 2022-12-06 | Morgan Stanley | $330 | 13.5% upside | |
| 2022-12-06 | UBS | $320 | 10.1% upside | |
| 2022-12-05 | Goldman Sachs | $230 | 20.9% downside | |
| 2022-05-24 | J.P. Morgan | $238 | 18.1% downside | |
| 2022-05-24 | Jefferies | $245 | 15.7% downside | |
| 2022-05-24 | Credit Suisse | $247 | 15% downside | |
| 2022-05-24 | H.C. Wainwright | $255 | 12.3% downside | |
| 2022-04-19 | J.P. Morgan | $223 | 23.3% downside | |
| 2021-05-05 | Credit SuisseTiago Fauth | $205 | 29.5% downside | |